Emicizumab-kxwh Subcutaneous and Fiasp FlexTouch
Determining the interaction of Emicizumab-kxwh Subcutaneous and Fiasp FlexTouch and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp, Fiasp Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Fiasp Injection
- Emicizumab-kxwh Subcutaneous-Fiber Lax
- Emicizumab-kxwh Subcutaneous-Fiber Laxative
- Emicizumab-kxwh Subcutaneous-FiberCon
- Emicizumab-kxwh Subcutaneous-FiberGen
- Emicizumab-kxwh Subcutaneous-Fibertab
- Fiasp FlexTouch-Emla
- Fiasp FlexTouch-Emla Topical
- Fiasp FlexTouch-Emo-Cort Scalp Solution Topical application
- Fiasp FlexTouch-Emo-Cort Topical application
- Fiasp FlexTouch-Emoquette
- Fiasp FlexTouch-Empagliflozin